ABSTRACT
We have characterized the monocarboxylate permease family of Saccharomyces cerevisiae comprising five proteins. We could not find any evidence that the monocarboxylate transporter-homologous (Mch) proteins of S. cerevisiae are involved in the uptake or secretion of monocarboxylates such as lactate, pyruvate or acetate across the plasma membrane. A yeast mutant strain deleted for all five MCH genes exhibited no growth defects on monocarboxylic acids as the sole carbon and energy sources. Moreover, the uptake and secretion rates of monocarboxylic acids were indistinguishable from the wild-type strain. Additional deletion of the JEN1 lactate transporter gene completely blocked uptake of lactate and pyruvate. However, uptake of acetate was not even affected after the additional deletion of the gene YHL008c, which had been proposed to code for an acetate transporter. The mch1-5 mutant strain showed strongly reduced biomass yields in aerobic glucose-limited chemostat cultures, pointing to the involvement of Mch transporters in mitochondrial metabolism. Indeed, intracellular localization studies indicated that at least some of the Mch proteins reside in intracellular membranes. However, pyruvate uptake into isolated mitochondria was not affected in the mch1-5 mutant strain. It is concluded that the yeast monocarboxylate transporter-homologous proteins perform other functions than do their mammalian counterparts.
Subject(s)
Carboxylic Acids/metabolism , Fungal Proteins/metabolism , Membrane Transport Proteins/metabolism , Monocarboxylic Acid Transporters/metabolism , Saccharomyces cerevisiae/metabolism , Biomass , Cell Membrane/enzymology , Cell Membrane/metabolism , Fungal Proteins/genetics , Gene Expression Regulation, Fungal/physiology , Genes, Fungal , Glucose/metabolism , Kinetics , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Transport Proteins/genetics , Mitochondria/metabolism , Mitochondria/physiology , Monocarboxylic Acid Transporters/genetics , Mutagenesis , Open Reading Frames , Oxygen Consumption , Pyruvic Acid/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , beta-Galactosidase/analysisABSTRACT
The increase in UV irradiation on earth due to the stratospheric ozone depletion represents a major environmental threat to the skin increasing its risk of photooxidative damage by UV-induced reactive oxygen species (ROS). Increased ROS load has been implicated in several pathological states including photoaging and photocarcinogenesis of the skin. Large efforts have been made to better define the involvement of distinct ROS in photocarcinogenesis and photoaging. Both pathological processes share common features; however, they reveal unique molecular characteristics which finally determine the fate of the cell and its host. As well as causing permanent genetic changes involving protooncogenes and tumor suppressor genes, ROS activate cytoplasmic signal transduction pathways that are related to growth differentiation, senescence, transformation and tissue degradation. This review focuses on the role of UV-induced ROS in the photodamage of the skin resulting in biochemical and clinical characteristics of photocarcinogenesis and photoaging. A decrease in the ROS load by efficient sunscreens and/or otherwise protective agents may represent a promising strategy to prevent or at least minimize ROS induced cutaneous pathological states.
Subject(s)
Aging , Reactive Oxygen Species/metabolism , Skin Neoplasms/etiology , Skin/radiation effects , Ultraviolet Rays , Aging/radiation effects , Animals , Connective Tissue , DNA Damage , Genes, Tumor Suppressor , Humans , Signal TransductionABSTRACT
We reported previously the elicitation of presumably monosynaptic evoked field potentials in the dentate gyrus of immobilized rats by stimulation of the medial septal nuclei. The septo-hippocampal pathway mediating this evoked potential (SHEP) is widely assumed to be cholinergic in nature. In order to further verify this assumption we studied the effects of muscarinic drugs on the SHEPs. Scopolamine as muscarinic cholinolytic and arecoline as muscarinic cholinergic agent influenced the SHEP in the expected manner. We conclude that the SHEP is elicited by cholinergic muscarinic activation.